Biodesix Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Biodesix, Inc. (BDSX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents26.2526.2843.0932.7162.13
Cash & Short-Term Investments26.2526.2843.0932.7162.13
Accounts Receivable8.607.685.073.6615.30
Inventory1.001.401.402.903.20
Other Current Assets4.645.725.187.258.71
Total Current Assets39.4839.6853.3343.6186.14
Non-Current Assets
Property, Plant & Equipment (Net)29.6029.618.824.183.18
Goodwill15.0315.0315.0315.0315.03
Intangible Assets5.877.919.8011.6213.26
Other Non-Current Assets7.266.865.921.663.46
Total Non-Current Assets57.7659.4139.5732.4834.93
Total Assets97.2499.1092.9176.10121.07
Current Liabilities
Accounts Payable2.1910.641.691.6616.75
Short-Term Debt0.020.050.050.0211.84
Current Portion of Long-Term Debt0.020.050.050.0211.84
Accrued Liabilities3.293.868.227.677.79
Deferred Revenue0.680.320.961.853.53
Other Current Liabilities0.6422.1510.3817.763.98
Total Current Liabilities14.3233.4222.8428.9632.13
Non-Current Liabilities
Long-Term Debt36.4160.3925.009.9915.93
Other Non-Current Liabilities0.820.7118.8016.6231.85
Total Non-Current Liabilities62.0561.1049.4627.4147.78
Total Liabilities76.3794.5272.3056.3779.90
Stockholders' Equity
Common Stock0.150.100.080.030.03
Retained Earnings-462.50-419.57-367.42-301.97-258.81
Additional Paid-in Capital483.23424.05387.95321.67299.95
Shares Outstanding7.274.813.881.540.00
Total Stockholders' Equity20.884.5820.6119.7341.17
Total Liabilities & Equity97.2499.1092.9176.10121.07